Asset Details
Do you wish to reserve the book?
Mechanics of EGF Receptor/ErbB2 kinase activation revealed by luciferase fragment complementation imaging
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
Mechanics of EGF Receptor/ErbB2 kinase activation revealed by luciferase fragment complementation imaging
Do you wish to request the book?
Mechanics of EGF Receptor/ErbB2 kinase activation revealed by luciferase fragment complementation imaging
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Journal Article
Mechanics of EGF Receptor/ErbB2 kinase activation revealed by luciferase fragment complementation imaging
2012
Overview
Binding of EGF to its receptor induces dimerization of the normally monomeric receptor. Activation of its intracellular tyrosine kinase then occurs through the formation of an asymmetric kinase dimer in which one subunit, termed the \"receiver\" kinase, is activated by interaction with the other subunit, termed the \"activator\" kinase [Zhang, et al. (2006) Cell 125: 1137–1149]. Although there is significant experimental support for this model, the relationship between ligand binding and the mechanics of kinase activation are not known. Here we use luciferase fragment complementation in EGF receptor (EGFR)/ErbB2 heterodimers to probe the mechanics of ErbB kinase activation. Our data support a model in which ligand binding causes the cis-kinase (the EGFR) to adopt the receiver position in the asymmetric dimer and to be activated first. If the EGF receptor is kinase active, this results in the phosphorylation of the trans-kinase (ErbB2). However, if the EGF receptor kinase is kinase dead, the ErbB2 kinase is never activated. Thus, activation of the kinases in the EGFR/ErbB2 asymmetric dimer occurs in a specific sequence and depends on the kinase activity of the EGF receptor.
Publisher
National Academy of Sciences,National Acad Sciences
Subject
/ Enzyme Activation - drug effects
/ Epidermal Growth Factor - pharmacology
/ Genetic Complementation Test
/ Imaging, Three-Dimensional - methods
/ Kinases
/ Peptide Fragments - metabolism
/ phosphotransferases (kinases)
/ Protein Multimerization - drug effects
/ Receptor, Epidermal Growth Factor - chemistry
/ Receptor, Epidermal Growth Factor - metabolism
/ Receptor, ErbB-2 - chemistry
/ Receptor, ErbB-2 - metabolism
/ Signal Transduction - drug effects
/ tyrosine
